On this page
Back to topCencora COR
Cencora is the 189th largest S&P 500 company by market cap, worth $63.7 billion. Its board has 11 directors, 10 of them independent. 4 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 12.3% of the company.
- CEO
- Robert P. Mauch
- Chair
- Dermot Mark Durcan
- Sector
- Health CareHealth Care Distributors
- Headquarters
- Conshohocken, Pennsylvania
- Founded
- 1985
- Market cap
- $63.7B
- 189th largest, 6 Nov 2026 close
- Price to sales
- 0.2
- Market cap over revenue
- Per employee
- $1.2M
- Market cap over employees
- Connections
- 5
- Companies sharing people
Financials
Reported figures
Figures from the release, against the same period a year earlier.
| Figure | Value | Change |
|---|---|---|
| Adjusted diluted EPS guidance - Fiscal Year 2026Fiscal Year 2026 | $17.90 | - |
Financial history
Twelve months to 30 Jun 2026, from Cencora's quarterly filings.
Quarters since Sep 2021
- Revenue
- $333B
- Up 5.1% on the year before
- Net income
- $2.6B
- 0.8% of revenue
- Free cash flow
- $4.1B
- Operating cash flow less capital spending
- P/E
- 24.3
- Market cap over net income
Quarterly results
Each quarter's revenue, net income and free cash flow.
Sep 2021 to Jun 2026
| Quarter | Revenue | Net income |
|---|---|---|
| Jun 2026 | $84.8B | $764M |
| Mar 2026 | $78.4B | $1.6B |
| Dec 2025 | $85.9B | $560M |
| Sep 2025 | $83.7B | $-340M |
| Jun 2025 | $80.7B | $687M |
| Mar 2025 | $75.5B | $718M |
| Dec 2024 | $81.5B | $489M |
| Sep 2024 | $79.1B | $3M |
| Jun 2024 | $74.2B | $483M |
| Mar 2024 | $68.4B | $421M |
| Dec 2023 | $72.3B | $602M |
| Sep 2023 | $68.9B | $351M |
| Jun 2023 | $66.9B | $480M |
| Mar 2023 | $63.5B | $435M |
| Dec 2022 | $62.8B | $480M |
| Sep 2022 | $61.2B | $295M |
| Jun 2022 | $60.1B | $407M |
| Mar 2022 | $57.7B | $548M |
| Dec 2021 | $59.6B | $449M |
| Sep 2021 | $58.9B | $438M |
Per employee
Twelve months to 30 Jun 2026, over 51,000 employees in Cencora's latest 10-K.
- Revenue
- $6.5M
- Operating profit
- $60K
- 0.9% of revenue
- Net income
- $51K
- 0.8% of revenue
Cencora's market cap since December 2008
Weekly, up to 6 Nov 2026
| Week ending | Market cap |
|---|---|
| 6 Nov 2026 | $63.7B |
| 26 Dec 2025 | $66.2B |
| 27 Dec 2024 | $43.9B |
| 29 Dec 2023 | $41.2B |
| 30 Dec 2022 | $34.1B |
| 31 Dec 2021 | $27.7B |
| 25 Dec 2020 | $19.8B |
| 27 Dec 2019 | $17.5B |
| 28 Dec 2018 | $15.7B |
| 29 Dec 2017 | $20.0B |
| 30 Dec 2016 | $17.2B |
| 25 Dec 2015 | $21.4B |
| 26 Dec 2014 | $20.0B |
| 27 Dec 2013 | $16.1B |
| 28 Dec 2012 | $10.1B |
| 30 Dec 2011 | $9.6B |
| 31 Dec 2010 | $9.4B |
| 25 Dec 2009 | $7.6B |
| 26 Dec 2008 | $5.4B |
Download Cencora's data as JSON, with the weekly market caps in billions of dollars from 5 Dec 2008.
Board and leadership
Board and officers
4 people here also hold roles at other S&P 500 companies.
Board from the proxy filed 22 Jan 2026; officers filed up to 30 Sep 2026
| Name | Title | Since | Independent | Committees | Age |
|---|---|---|---|---|---|
| Directors (11) | |||||
| Dermot Mark DurcanChairIndependent · since 2015 · Executive (chair)Retired CEO, Micron Technology, Inc.Other boards: ASML Holding N.V. | |||||
| Robert P. MauchPresident & CEONot independent · since 2024 · Executive | |||||
| Werner BaumannDirectorIndependent · since 2023 · Audit (chair), Compensation and Succession Planning, Executive, Special Litigation (chair)Retired Chairman, CEO and Chief Sustainability Officer, Bayer AG | |||||
| Frank ClyburnDirectorIndependent · since 2024 · Compliance and Risk, FinanceRetired CEO, International Flavors & Fragrances Inc.Other boards: Revolution Medicines | |||||
| Ellen CooperDirectorIndependent · since 2026Chairman, President and CEO, Lincoln National CorporationOther boards: Lincoln National | |||||
| Lon R. GreenbergDirectorIndependent · since 2013 · Compliance and Risk, Executive, Finance, Governance, Sustainability and Corporate Responsibility (chair)Retired CEO, UGI Corporation | |||||
| Lorence H. Kim, M.D.DirectorIndependent · since 2022 · Compensation and Succession Planning, Executive, Finance (chair)Co-Founder and Managing Partner, Ascenta CapitalOther boards: Revolution Medicines | |||||
| Redonda MillerDirectorIndependent · since 2023 · Compliance and Risk (chair), Executive, Governance, Sustainability and Corporate Responsibility, Special LitigationPresident, The Johns Hopkins Hospital | |||||
| Dennis M. NallyDirectorIndependent · since 2020 · Audit, Compensation and Succession Planning (chair), ExecutiveRetired Chairman, PricewaterhouseCoopers-International Ltd.Also at Morgan Stanley | |||||
| Lori RyerkerkDirectorIndependent · since 2025Retired Chairman and CEO, Celanese CorporationAlso at Eaton and Norfolk Southern | |||||
| Lauren M. TylerDirectorIndependent · since 2023 · Audit, Governance, Sustainability and Corporate Responsibility, Special LitigationRetired EVP and Global Head of Human Resources, JP Morgan Asset and Wealth ManagementAlso at Centene | |||||
| Officers (4) | |||||
| Eva C. BorattoChief Financial OfficerAlso at United Parcel ServiceLast filed 30 Jun 2026 | |||||
| Elizabeth S. CampbellExecutive Vice PresidentLast filed 25 Aug 2026 | |||||
| Lazarus KrikorianSVP & Chief Accounting OfficerLast filed 2 Sep 2026 | |||||
| Pawan VermaEVP, Chief Data & Info OfficerLast filed 24 Nov 2025 | |||||
Companies that share people with Cencora
Each person's title here, then at the other company.
- Centene CNC
- Lauren M. Tyler: Director here, Director there
- Eaton ETN
- Lori Ryerkerk: Director here, Director there
- Morgan Stanley MS
- Dennis M. Nally: Director here, Director there
- Norfolk Southern NSC
- Lori Ryerkerk: Director here, Director there
- United Parcel Service UPS
- Eva C. Boratto: Chief Financial Officer here, Director there
Owners and trading
Largest institutional holders
Each fund group's share of Cencora. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 6 Nov 2025 to 6 Nov 2026
Directors and officers sold $15.4 million of stock in 13 sales and bought $2.3 million in 3 purchases in the 12 months to 6 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 2 Nov 2026Sale | Lazarus KrikorianSVP & Chief Accounting Officer | $326K |
| 1 Oct 2026Sale | Lazarus KrikorianSVP & Chief Accounting Officer | $299K |
| 16 Sep 2026Sale | Lon R. GreenbergDirector | $411K |
| 1 Sep 2026Sale | Lazarus KrikorianSVP & Chief Accounting Officer | $321K |
| 24 Aug 2026Sale | Elizabeth S. CampbellExecutive Vice President | $3.7M |
| 22 Jun 2026Buy | Lauren M. TylerDirector | $149K |
| 18 Jun 2026Buy | Dermot Mark DurcanChair | $1.1M |
| 28 May 2026Buy | Dermot Mark DurcanChair | $1.1M |
| 20 Feb 2026Sale | Robert P. MauchPresident & CEO | $1.4M |
| 18 Feb 2026Sale | Robert P. MauchPresident & CEO | $479K |
Showing 10 of 16 trades
Trades by members of Congress and officials
Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.
Trades from 27 Oct 2023 to 27 Oct 2026
7 people disclosed 14 purchases and 16 sales of Cencora stock since October 2023.
| Date | Member or official | Amount |
|---|---|---|
| 4 Sep 2026 | Rohit KhannaHouse, D-CA · Bought | $1K to $15K |
| 12 Jun 2026 | Donald J TrumpPresident · Bought | $50K to $100K |
| 18 May 2026 | Donald J TrumpPresident · Sold | $100K to $250K |
| 11 May 2026 | Donald J TrumpPresident · Sold | $50K to $100K |
| 6 May 2026 | Jared MoskowitzHouse, D-FL · Sold | $1K to $15K |
| 6 May 2026 | Jared MoskowitzHouse, D-FL · Sold | $1K to $15K |
| 27 Apr 2026 | Donald J TrumpPresident · Bought | $50K to $100K |
| 27 Apr 2026 | Donald J TrumpPresident · Bought | $15K to $50K |
| 13 Apr 2026 | Rohit KhannaHouse, D-CA · Sold | $15K to $50K |
| 31 Mar 2026 | Jared MoskowitzHouse, D-FL · Bought | $1K to $15K |
Showing 10 of 30 trades
Workforce and hiring
Workforce
Headcount at 30 Sep 2025
- Employees
- 51,000
Employees, last 9 fiscal years
Up 132% in five years, from 22,000 in 2020 to 51,000 in 2025.
As of September 30, 2025, we had more than 51,000 employees globally, of which approximately 47,000 were full-time employees and approximately 41% were U.S.-based employees.5Table of Contents As of September 30, 2025, approximately 24% of our global employees were covered by collective bargaining agreements, nearly all of whom were employees located outside of the U.S.
Open roles
Jobs listed on Cencora's careers site, each counted once.
Daily, up to 3 Nov 2026
- Open roles
- 1,025
- On 3 Nov 2026
- Change
- +3
- Up 0.3% since 27 Oct 2026
- Top function
- Operations & Supply Chain
- 44% of open roles
- Remote
- 15%
- 41% do not say
Open roles in detail
27 Oct 2026 to 3 Nov 2026
Most are in the US (40%), then Canada and the UK.
| Role | Posted |
|---|---|
| Accounts Receivable Clerk II - ReturnsVilnius, Lithuania | 3 Nov 2026 |
| AI Developer 1Pune, India | 3 Nov 2026 |
| AI Developer 2Pune, India | 3 Nov 2026 |
| Ambulatory Pharmacy Technician IIDallas, Texas, United States of America | 3 Nov 2026 |
| ApotekmedarbeiderLarvik, Norway | 3 Nov 2026 |
| ApotekteknikerStange, Norway | 3 Nov 2026 |
| ApotekteknikerDrammen, Norway | 3 Nov 2026 |
| Assistant, Specialty PharmacyEdmonton, Alberta, Canada | 3 Nov 2026 |
| Day | Open roles |
|---|---|
| 3 Nov 2026 | 1,025 |
| 2 Nov 2026 | 1,007 |
| 1 Nov 2026 | 1,008 |
| 31 Oct 2026 | 1,009 |
| 30 Oct 2026 | 1,007 |
| 29 Oct 2026 | 1,015 |
| 28 Oct 2026 | 1,008 |
| 27 Oct 2026 | 1,022 |
Timeline
Leadership changes, layoffs and insider sales
7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025
7 departures and 6 appointments of directors and officers and 7 large insider sales in the last two years.
Insider sales of $1 million or more, and the largest tenth of Cencora's insider sales.
Events, newest first
- 24 Sep 2026 Robert E. Sanchez appointedDirector, effective 1 Oct 2026
- 24 Aug 2026 Elizabeth S. Campbell sold $3.7MExecutive Vice President
- 13 Aug 2026 Lorence H. Kim, M.D. resignedDirector
- 10 Jun 2026 Silvana Battaglia retiredExecutive Vice President and Chief Human Resources Officer, effective 12 Jul 2026
- 10 Jun 2026 Samantha L. Hammock appointedExecutive Vice President and Chief Human Resources Officer, effective 13 Jul 2026
- 23 May 2026 Eva C. Boratto appointedExecutive Vice President and Chief Financial Officer, effective 29 Jun 2026
- 17 Mar 2026 James F. Cleary retiredExecutive Vice President and Chief Financial Officer, effective 30 Jun 2026
- 20 Feb 2026 Robert P. Mauch sold $1.4MPresident & CEO
Showing 8 of 20 events
| Date | Event | Filing |
|---|---|---|
| 24 Sep 2026 | Robert E. Sanchez appointedDirector, effective 1 Oct 2026 | 8-K |
| 24 Aug 2026 | Elizabeth S. Campbell sold $3.7MExecutive Vice President | Form 4 |
| 13 Aug 2026 | Lorence H. Kim, M.D. resignedDirector | 8-K |
| 10 Jun 2026 | Silvana Battaglia retiredExecutive Vice President and Chief Human Resources Officer, effective 12 Jul 2026 | 8-K |
| 10 Jun 2026 | Samantha L. Hammock appointedExecutive Vice President and Chief Human Resources Officer, effective 13 Jul 2026 | 8-K |
| 23 May 2026 | Eva C. Boratto appointedExecutive Vice President and Chief Financial Officer, effective 29 Jun 2026 | 8-K |
| 17 Mar 2026 | James F. Cleary retiredExecutive Vice President and Chief Financial Officer, effective 30 Jun 2026 | 8-K |
| 20 Feb 2026 | Robert P. Mauch sold $1.4MPresident & CEO | Form 4 |
| 20 Jan 2026 | Ellen G. Cooper appointedDirector | 8-K |
| 20 Jan 2026 | Robert P. Mauch sold $1.8MPresident & CEO | Form 4 |
| 19 Dec 2025 | Elizabeth S. Campbell sold $1.1MExecutive Vice President | Form 4 |
| 18 Dec 2025 | Robert P. Mauch sold $1.8MPresident & CEO | Form 4 |
| 17 Dec 2025 | Lazarus Krikorian sold $1.4MSVP & Chief Accounting Officer | Form 4 |
| 18 Nov 2025 | Robert P. Mauch sold $1.9MPresident & CEO | Form 4 |
| 27 Aug 2025 | Steven H. Collis retiredExecutive Chairman of the Board, effective 30 Sep 2025 | 8-K |
| 27 Aug 2025 | D. Mark Durcan appointedChairman of the Board, effective 1 Oct 2025 | 8-K |
| 21 May 2025 | Ornella Barra resignedDirector, effective 27 May 2025 | 8-K |
| 21 May 2025 | Lori J. Ryerkerk appointedDirector, effective 1 Jun 2025 | 8-K |
| 22 Jan 2025 | Kathleen W. Hyle retiredDirector, effective 6 Mar 2025 | 8-K |
| 22 Jan 2025 | Richard W. Gochnauer retiredDirector, effective 6 Mar 2025 | 8-K |
Not on file: no WARN layoff notices under its own name or a listed subsidiary's since November 2023.